Legal & Pharmacologic Considerations
for the Management of Substance Use Disorders
for professionals in psychology, behavioral health, social work, and substance use
Presented by Dr. Nathan Sutera & Dr. Ally Dering-Anderson
Videos
The following videos include Part 1 and Part 2 of Drs. Ally Dering-Anderson and Nathan Sutera’s training on the “Legal and Pharmacologic Considerations for the Management of Substance Use Disorders.” This presentation discusses the management of substance use disorders (SUDs). Part 1 focuses on the legal considerations regarding relevant rules and regulations. Part 2 focuses on currently available evidence-based pharmacologic treatment options.
Part 1:
Legal and Pharmacologic Considerations for the Management of Substance Use Disorders
(Dr. Ally Dering-Anderson)
Part 2:
Legal and Pharmacologic Considerations for the Management of Substance Use Disorders
(Dr. Nathan Sutera)
Description:
This presentation discusses the management of substance use disorders (SUDs). The first half of the presentation focuses on the legal considerations regarding relevant rules and regulations, including the federal Comprehensive Addiction and Recovery Act (CARA), Drug Addiction Treatment Act (DATA), and the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) Act requirements and changes resulting from the 2022 Omnibus Bill. Research on access issues for a variety of populations is presented to illustrate the impact of the 1970 Comprehensive Drug Abuse Prevention and Control Act. Nebraska laws on medication-assisted treatment (MAT) and life-saving drugs and emerging therapies is also discussed from a legal perspective. The second half of the training focuses on currently available evidence-based pharmacologic treatment options.
Date Presented: Thurs., Feb. 23, 2023 1:00pm – 4:00pm (Central)
Date Training Expires: Feb. 23, 2025
Objectives:
- Describe the role of psychosocial interventions and other non-pharmacologic modalities in the treatment of SUDs and the importance of a multimodal approach.
- Compare and contrast current treatment modalities for the management of each SUD including mechanism of action, side effects, drug interactions, warnings/precautions, and other patient-specific factors.
- Identify essential information for each pharmacologic treatment option to share with patients when discussing the benefits and risks of each medication.
- Discuss federal laws, including the CARA, DATA, and the SUPPORT Act.
Instructional Level: Intermediate
Supporting Material
About the Speaker
Dr. Ally Dering-Anderson
Dr. Dering-Anderson is a Clinical Associate Professor in the Department of Pharmacy Practice & Science at the University of Nebraska College of Pharmacy. She coordinates and teaches Law & Ethics, OTC Products, Advocacy, Medical Cannabis, Point-of-Care Testing, and Immunizations. She is also the preceptor for a Public Policy rotation for senior-level pharmacy students. Ally has presented nationally and internationally on pharmacy subjects.
Dr. Nathan Sutera
Dr. Sutera graduated from the South Dakota State University College of Pharmacy in 2018 and pursued residency training at CHI Health Immanuel and Center for Behavioral Medicine in Kansas City to specialize in psychiatric pharmacy. Following residency, Dr. Sutera began working at Nebraska Medicine in the Psychiatric Emergency Services (PES) unit and UNMC College of Pharmacy as an assistant professor where he teaches topics regarding the diagnosis and management of psychiatric and substance use disorders.
These trainings were funded in whole or in part by funds from the SAMHSA Community Mental Health Block Grant, SAMHSA Substance Abuse Prevention and Treatment Block Grant and state funds sub-granted from the Nebraska Department of Health and Services, Division of Behavioral Health.